This Belgian BioTech Startup Just Raised Millions for its Meat Replacement Tech

Jan de Vries · 2026-08-25

Let's talk about what's happening over in Brussels. It's not just politics and waffles. There's a quiet revolution happening in the food tech space, and a startup named MAASH is right at the center of it. They've just pulled in a serious round of funding to scale their work on mycoprotein. Now, you might be asking, what exactly is mycoprotein? Think of it as a protein grown from fungi through fermentation. It's a sustainable ingredient that's making waves as a meat alternative. MAASH isn't just playing in the lab anymore. They're moving their operation to an industrial stage, and this new cash injection is the fuel for that leap. ### The Funding Breakdown: Who's Betting on Mycoprotein? The total funding package comes to roughly $13.4 million. That's a significant vote of confidence. It's a blend of different financing sources, which is pretty interesting. - About $6.4 million came from an equity raise, bringing five new investors to the table: Ambra Capital, InvestPro, Bpifrance, Amorçage Industriel, Nordzucker and Tereos. - Then there's nearly $4.7 million in support through a French government program called Première Usine. - Finally, a loan of about $2.2 million rounds it all out. This mix shows a belief from both private investors and public initiatives in France's "France 2030" plan. It’s not just about the money; it’s about strategic backing. Frédéric Van Gansberghe, MAASH's co-founder and Chairman, put it best: "Our industrial fermentation experience, combined with the arrival of our new partners, will allow us to move quickly through our technical and commercial scale-up." ### From a Startup Idea to Industrial Execution MAASH was founded back in 2021 by Van Gansberghe and Gaspard Gilbert. Their focus has been laser-sharp from the start: developing mycoprotein as a sustainable, scalable ingredient for the wider food industry. They're a B2B player. They're not making the final veggie burger you buy at the store. Instead, they supply food companies with their key ingredient, called LoCylia. These companies then use it to "enhance" their products. We're talking about reducing meat content by 10 to 30% in existing products or creating entirely new vegan and vegetarian lines. The secret is in the fermentation process. MAASH claims to have precise control over parameters like temperature and oxygen levels. This isn't just about growing a lot of protein; it's about ensuring that protein still tastes good and has the right texture. ### A Strategic Site and New Leadership for Scale Two years ago, MAASH made a savvy move by acquiring an old industrial fermentation site in Carling-Saint-Avold, France. It gave them a ready-made industrial base. Now, they're transitioning from planning to doing. Part of that transition involves bringing in seasoned leadership. They've appointed Samah Garringer as their new CEO, set to join in September 2026. She's got over 25 years of experience in food ingredients and scaling up operations, having held executive roles at major players like DSM and Avril Group. Garringer said, "I am thrilled to join MAASH at this pivotal moment. Together with the team and our new partners, we will... build a resilient, cost-competitive platform to bring nutritious, sustainable mycoprotein to market at scale." As she comes on board, co-founder Gaspard Gilbert will shift to Chief Commercial Officer, focusing on strategic partnerships and commercial relationships. ### What Does This Money Actually Fund? This isn't just about padding the bank account. The funding has a clear, concrete purpose. It will directly support the launch of MAASH's new demonstration plant. Think of it as a pilot facility with a fermentation capacity of about 424 cubic feet. The goal from there is massive. This demonstration phase is meant to pave the way for scaling up to an annual production target of 11,000 tons. That's moving from a promising startup to a major industrial supplier. So, what's the takeaway for professionals watching the European startup and food tech scene? It's a signal. A signal that fermentation-based proteins are moving beyond niche science projects. They're attracting serious capital and experienced industry talent to solve a real-world problem: creating sustainable, scalable food sources. MAASH's journey from a 2021 startup to an industrially-focused company with over $13 million in backing is a case study worth watching.